HOME >> MEDICINE >> NEWS
Emory studies COGNIShunt device for Alzheimer's treatment

Neurologists at Emory University are studying a possible new treatment for Alzheimers disease using a device called the COGNIShunt, designed to drain cerebrospinal fluid (CSF) from the skull and into the abdominal cavity. By reducing the build-up of CSF around the brain, doctors hope this device will help to stabilize the disease.

CSF is the fluid that fills the empty spaces around the brain and spinal cord. The body naturally produces, absorbs, drains and replenishes the fluid. But with age, the replenishing process slows. "Past research shows that toxic and inflammatory substances are found in the cerebrospinal fluid of Alzheimers patients, which in turn, may lead to brain cell damage," says Allan Levey, M.D., Ph.D., professor of neurology, Emory University School of Medicine and principal investigator of the Emory study. "We hope the COGNIShunt will help to drain off some of those toxins and allow the CSF to better replenish itself."

Shunting has long been used as treatment for hydrocephalus, a condition in which an abnormal accumulation of CSF causes neurological problems, including dementia, problems walking and incontinence.

In the Emory study, surgeons will surgically implant the COGNIShunt into a normal cavity, or ventricle, in the brain. Then they will tunnel a tube through the neck and into the abdominal cavity for proper drainage. It is a relatively short and common procedure that usually requires a one-to two-day hospital stay.

The duration of the study, at Emory and 11 other sites, is 18 months. The first nine months of the study is double-blind placebo, meaning all participants will receive the shunt but the shunt will not be open, or working, in the placebo group. The second nine months of the trial is open-label, meaning participants in the placebo group can have their shunt revised to be opened, so it will work. Eunoe, Inc., the maker of the COGNIShunt, is funding this clinical trial to assess the effective
'"/>

Contact: Janet Christenbury
jmchris@emory.edu
404-727-8599
Emory University Health Sciences Center
21-Mar-2002


Page: 1 2

Related medicine news :

1. Emory Study finds HIV is not an independent risk factor for severe heart disease
2. Emory cardiologists present research at AHA scientific sessions in New Orleans, Nov. 7 - 10
3. Emory study finds mental health and heart disease tightly linked
4. Emory conference to educate health professionals about metabolic syndrome
5. Emory researcher examines effects of antiepileptic drugs on pregnant women and their offspring
6. Emory researchers find race and gender gaps in treatment of heart attack
7. Emory, GlaxoSmithKline, NIMH enter public-private partnership to develop new drugs for depression
8. Emory and CDC scientists explore why most breastfed infants of HIV-positive mothers resist infection
9. Emory scientists find marker for long-term immunity
10. Emory scientists find oral tetrahydrobiopterin can reduce high blood pressure
11. Emory scientists link atrial fibrillation with decrease in nitrous oxide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... ... ... She went from learning disabled to honor roll – all because of some ... tests,” performed by Deborah Zelinsky, O.D. , founder of the Mind-Eye Institute in ... of visual awareness, she could only see what was directly in front of her ...
(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... releasing its first ever Cannabis Industry Report . The study—which considers consumers’ ... emerging intersections with retail and manufacturing, offering insight into what kinds of products ...
(Date:4/17/2019)... ... ... Kadan Homecare, an award-winning provider of quality, non-medical home care to Atlanta area families ... of Home Care® – Provider of Choice and Employer of Choice Awards from Home ... on client and caregiver satisfaction scores gathered by Home Care Pulse. Kadan is now ...
(Date:4/17/2019)... ... April 17, 2019 , ... Purple ... symptoms. This California-made supplement was designed to lessen the negative effects of ... for purchase via GotPurpleTree.com and Amazon.com . , According to ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... in revolutionary diagnostic technologies. This episode is scheduled to air 3Q 2019 on ... Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... April 17, 2019 , ... ... antibodies, kits, and services, today announced that they have formalized partnerships with ... that encourage science and environmental education, arts, and support for the underprivileged ...
(Date:4/17/2019)... ... , ... Clinical trials of new cancer treatments have historically focused on disease ... advances in medical oncology and genomic characterization of tumors, we are now able to ... “basket trials.” This ability has created a paradigm shift in oncology trials. , In ...
(Date:4/17/2019)... Mass. (PRWEB) , ... April ... ... dba MyMedicalShopper , a leading provider of healthcare price transparency solutions, ... based in Massachusetts, are partnering to give consumers more choice and control ...
Breaking Medicine Technology:
Cached News: